Disrupting tiny droplets that switch on cancer genes may be a strategy for treating a rare #kidneycancer known as ...

Clinicians from the Johns Hopkins Kimmel Cancer Center and four other institutions have demonstrated that doctors can gain a ...

Some patients with lupus who possess specific antibodies are at a higher risk of thrombotic events such as a blood clot, ...

Learn more about our Cardiac Rehab program. Once you have physician approval to begin the Outpatient Cardiac Rehabilitation Program, our staff performs an evaluation, including a medical history, ...

The Johns Hopkins Transplant Research Center (TRC) is a multidisciplinary research partnership between the Department of Medicine's Division of Infectious Diseases and the Department of Surgery's ...

Knowing your correct fluid pressure will help your care team to better understand your condition and recommend appropriate medicine or surgery. Intracranial pressure (ICP) monitoring is a diagnostic ...

Whether you're looking for the latest biomedical discovery information, innovative health tips or expert opinions from some of the world's leading physicians, Johns Hopkins can help. Below you'll find ...

The Academy at Johns Hopkins supports the continued research, teaching and service of retired faculty of the Johns Hopkins University School of Medicine, the Johns Hopkins Bloomberg School of Public ...

The mission of Johns Hopkins Medicine is to improve the health of the community and the world by setting the standard of excellence in medical education, research and clinical care. Diverse and ...

Several states are reporting cases of measles, a highly contagious viral disease. Both children and adults can get measles. Before going to a clinic or emergency room, it’s important to check with ...

Speaker: Daniel Brodie, M.D. Section Chief for Critical Care at the Milstein and Allen Hospitals, Director of the Medical ICUs, Director of the Adult ECMO Program, Director of the Center for Acute ...

Our center is leading or participating in several clinical trials for both relapsing remitting and primary progressive MS. Our team is particularly dedicated to finding better treatments for ...